Medigene NA O.N. (MDG1k)

2.15
+0.06(+2.87%)
  • Volume:
    18,245
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    2.09 - 2.15

MDG1k Overview

Prev. Close
2.09
Day's Range
2.09-2.15
Revenue
14.9M
Open
2.15
52 wk Range
1.78-4.55
EPS
-
Volume
18,245
Market Cap
52.32M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
25,358
P/E Ratio
5.50
Beta
0.75
1-Year Change
-9.13%
Shares Outstanding
24,562,658
Next Earnings Date
22 Mar 2023
What is your sentiment on Medigene?
or
Vote to see community's results!

Medigene NA O.N. News

Medigene NA O.N. Analysis

Medigene NA O.N. Company Profile

Medigene NA O.N. Company Profile

  • Type:Equity
  • Market:Germany
  • ISIN:DE000A1X3W00
  • WKN:A1X3W0

Medigene AG is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-based immunotherapies. It develops three platforms: T-cell receptor (TCR)-modified T cells for adoptive T-cell therapy as treatments for patients with tumor burdens; Dendritic cell (DC) vaccines for the treatment of low tumor burdens, such as minimal residual disease or for use in combination therapies, and T-cell-specific monoclonal antibodies (TABS) to identify T cells based on their T-cell receptors. The Company operates offices in Martinsried in Germany, as well as in Washington DC and San Diego in the United States.

Read More

Analyst Price Target

Average8.95 (+316.28% Upside)
High14.00
Low3.90
Price2.15
No. of Analysts2
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyStrong SellStrong Sell
Technical IndicatorsBuyBuySellStrong SellStrong Sell
SummaryStrong BuyStrong BuyNeutralStrong SellStrong Sell